Antibody-targeted biodegradable nanoparticles for cancer therapy

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Nanotechnology presents significant potential for advancing cancer diagnosis and therapy.
• Nanoparticles (NPs) are engineered for targeted delivery of diagnostic and therapeutic agents to tumor sites.
• Surface functionalization of NPs with tumor-specific ligands (e.g., antibodies, peptides) is key for targeted delivery.

Purpose of the Study:

• To review recent advancements in the design of multifunctional nanoparticles for cancer therapy.
• To focus on antibody-targeted nanoparticles and their application in targeted drug delivery.
• To highlight liposomal, polymeric, and protein-based delivery systems in this context.

Main Methods:

• Review of current literature on nanotechnology in cancer research.
• Analysis of nanoparticle functionalization strategies for tumor targeting.
• Discussion of various nanoparticle-based delivery systems, including liposomes, polymers, and proteins.

Main Results:

• Antibody-targeted NPs demonstrate enhanced efficacy in cancer treatment.
• Targeted delivery via functionalized NPs significantly reduces side effects.
• Multifunctional NP designs are crucial for optimized cancer diagnosis and therapy.

Conclusions:

• Nanoparticle-based targeted delivery is a promising strategy for improved cancer treatment.
• Further development of multifunctional antibody-targeted NPs can revolutionize oncology.
• Liposomal, polymeric, and protein-based systems are key platforms for targeted cancer therapy.